0001104659-23-062377.txt : 20230518
0001104659-23-062377.hdr.sgml : 20230518
20230518203522
ACCESSION NUMBER: 0001104659-23-062377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coffin Robert
CENTRAL INDEX KEY: 0001376492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38596
FILM NUMBER: 23937745
MAIL ADDRESS:
STREET 1: C/O BIOVEX GROUP, INC.
STREET 2: 34 COMMERCE WAY
CITY: WOBURN
STATE: MA
ZIP: 10801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Replimune Group, Inc.
CENTRAL INDEX KEY: 0001737953
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822082553
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
BUSINESS PHONE: (781) 222-9600
MAIL ADDRESS:
STREET 1: 500 UNICORN PARK
CITY: WOBURN
STATE: MA
ZIP: 01801
4
1
tm2316199-8_3seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-05-16
0
0001737953
Replimune Group, Inc.
REPL
0001376492
Coffin Robert
C/O REPLIMUNE GROUP, INC.
500 UNICORN PARK DRIVE
WOBURN
MA
01801
1
1
0
0
President & Chief R&D Officer
0
Common Stock
2023-05-16
4
S
0
7861
18.05
D
1833336
D
Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.
The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.23. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ Shawn Glidden, attorney-in-fact
2023-05-18